SIRT1 and obesity due to melanocortin 4 receptor deficiency: Activation of SIRT1 by the activator resveratrol or overexpression of SIRT1 can be beneficial for the treatment of metabolic and neurodegenerative diseases such as type 2 diabetes, obesity, Alzheimer’s disease, and Parkinson’s disease.